News & Articles

These findings are crucial as rapidly spreading variants of SARS-CoV-2 have been reported in various countries

The novel self-labelling mammalian display method identifies antibodies against membrane proteins in their native configuration

Guest editorial: Technology to meet the needs of faster vaccine development

Watch this on demand webinar to learn about SpyTag-SpyCatcher technology and how TrailBlazer Antibodies can transform your assay development

Working with the UK government, first vaccinations are to begin early in the new year

The real-time RT-PCR assay can simultaneously detect and differentiate 8 target genes, the first and only test to do so in the world

Top talks and resources exploring the latest research and methods in the field are now available on demand

Dr. Jacqueline Barnett and Dr. Joel Allainguillaume discuss their work to develop handheld detectors to combat the spread of cacao swollen shoot virus and arrest the decline in the cocoa industry

Elecsys Anti-SARS-CoV-2 S test specifically detects antibodies against the SARS- CoV-2 spike protein

Explore ways to improve time to result in critical pathways such as sepsis

In a 17-4 vote, the FDA vaccine advisory committee recommended that Pfizer/BioNTech’s COVID-19 vaccine should be distributed to the U.S.

Watch this on-demand webinar to learn how COVID immune responses can be assessed using a novel microfluidic in-solution immunoassay platform

Access SARS-CoV-2 IgG II test is a semi-quantitative assay that measures patient’s relative level of antibodies in response to a previous SARS-CoV-2 infection

Phase 3 interim analysis including 131 Covid-19 cases indicates that the vaccine is 70.4% effective when combining data from two dosing regimens

Two different dosing regimens demonstrated efficacy with one showing a better profile